A Phase IIb Two-Cohort, Randomised, Placebo controlled, Double blind, Multi-centre, Dose-ranging Study of AZD5462 in Stable Patients with Chronic Heart Failure

Project: Research

Status	Active
Effective start/end date	12/2/24 → 12/31/27

Project Details